Poloxamer-188 Adjuvant Efficiently Maintains Adaptive Immunity of SARS-CoV-2 RBD Subunit Vaccination through Repressing p38MAPK Signaling
2022-06-21
https://www.mdpi.com/2076-393X/10/5/715
2022-06-21
https://www.mdpi.com/2076-393X/10/5/715